Mathew Koretsky

22 posts

Mathew Koretsky banner
Mathew Koretsky

Mathew Koretsky

@mkoretsky1

machine learning engineer | @DataTecnica | @NIH @BiomedArena | @uvmvermont | views/tweets are my own

Washington, DC Se unió Aralık 2022
83 Siguiendo26 Seguidores
Mathew Koretsky retuiteado
The Lancet Digital Health
The Lancet Digital Health@LancetDigitalH·
NEW Resource: CARDBiomedBench: a benchmark for evaluating the performance of #LLMs in biomedical research. Read it here: buff.ly/FQm6OEu
The Lancet Digital Health tweet media
English
0
5
5
534
Mathew Koretsky retuiteado
Faraz Faghri
Faraz Faghri@FarazFaghri·
🚀 We just launched DTAgent-AD, a scientific reasoning agent built to accelerate biomedical research and specialized Alzheimer’s & neurodegenerative disease research. DTAgent-AD is a domain-tuned agent trained on trace data from real biomedical tasks, not a general chatbot.
Faraz Faghri tweet media
English
2
8
37
6.2K
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
Stay tuned to see how the biomedical agents we’re building at @DataTecnica stack up against these models!
English
0
2
0
95
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
Despite boasting impressive performance across a range of categories, the latest frontier LLMs (Gemini 3 Pro, Claude Opus 4.5, and GPT-5.2) still struggle to balance accuracy and safety on CARDBiomedBench, our biomedical QA benchmark 👀
Faraz Faghri@FarazFaghri

Frontier models are moving fast, but are they getting better at biomedical research? We just ran a fresh benchmark update using CARDBiomedBench, our evaluation suite for genetics, disease associations, and drug discovery QA. Instead of looking only at “did it answer?”

English
1
1
1
93
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
Stay tuned to see how our Agents stack up against the latest base LLMs on biomedical question-answering tasks!
English
0
0
0
19
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
👀 Our new Knowledge Agents make BiomedArena.AI more powerful than ever. 🧬 Get insights backed by the journals and databases that biomedical researchers use daily. 📄 Read the blog more more info: datatecnica.com/blog/-biomedar…
Faraz Faghri@FarazFaghri

🧬 New at BiomedArena.AI: smarter Biomedical Knowledge Agents + Knowledge Mode We just shipped the latest update to BiomedArena.AI, the world’s first platform for benchmarking LLMs on biomedical research tasks.

English
1
0
0
75
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
We continue to evaluate these new models on our benchmark, CARDBiomedBench. Despite significant progress, there are still no models that balance response accuracy and safety on biomedical questions 👀
BiomedArena.AI@BiomedArena

We evaluated 12 top models using CARDBiomedBench, a biomedical benchmark with 68K+ expert QA pairs across GWAS, SMR, drug discovery & more. 🧠 No model aced both safety and accuracy. 🤖 GPT-4o = bold but risky 🤔 Claude-4.0 = cautious but wrong More is coming soon.

English
0
0
0
79
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
🚨BiomedArena is live🚨 In a partnership with @lmarena_ai, our team at @DataTecnica has released a feedback-rich platform to evaluate LLM performance on real-world biomedical questions. ⚔️Access the arena: biomedarena.ai 📄Read the blog post: news.lmarena.ai/introducing-bi…
Arena.ai@arena

🧬 BiomedArena is here! We’re honored to partner with @DataTecnica and @NIH CARD, who developed BiomedArena to evaluate LLMs for biomedical discovery, and to help expand this domain-specific track in community-driven evaluations. 🧪 Biomedical science is complex, high-stakes, and constantly evolving. 📊 CARDBiomedBench & tabular reasoning tests show that no current model can reliably meet the reasoning & domain-specific knowledge demands of biomedical researchers. Learn more about BiomedArena in thread 👇 🧵 #AI #LLMs #BiomedicalAI #AIEvaluation #OpenScience #LMArena #BiomedArena #NIH

English
1
3
8
848
Mathew Koretsky retuiteado
Daniel Khashabi 🕊️
Daniel Khashabi 🕊️@DanielKhashabi·
🚨New LLM benchmark🚨 We're releasing BiomedSQL🔬 for tabular reasoning over large-scale biomedical databases. This includes questions based on implicit scientific conventions—like statistical thresholds, effect direction, and drug approval status. 📄 Preprint: arxiv.org/pdf/2505.20321 📊 Dataset: huggingface.co/datasets/NIH-C… Lead by Matt Koretsky at @DataTecnica
Daniel Khashabi 🕊️ tweet media
English
0
7
15
1.2K
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
We believe this benchmark is a critical step towards building trustworthy text-to-SQL systems that can increase efficiency of lookups for PIs and SMEs, democratize access to biomedical knowledge, and accelerate discovery
English
1
0
0
49
Mathew Koretsky
Mathew Koretsky@mkoretsky1·
Can LLMs perform reliably as biomedical data analysts? TL;DR: We created the first benchmark designed to challenge LLMs ability to apply scientific reasoning in text-to-SQL generation over biomedical databases, revealing a 30-40% gap between SOTA models and expert performance
English
1
1
1
223
Mathew Koretsky retuiteado
Daniel Khashabi 🕊️
Daniel Khashabi 🕊️@DanielKhashabi·
Long-form inputs (e.g., needle-in-haystack setups) are the crucial aspect of high-impact LLM applications. While previous studies have flagged issues like positional bias and distracting documents, they've missed a crucial element: the size of the gold/relevant context. In our latest study, we look into how the size of these gold contexts impacts LLM performance in needle-in-a-haystack scenarios. The verdict? **Smaller gold contexts severely amplify positional bias.** Why should you care? If you're developing LLMs to sift through large number of documents of varying sizes, beware: a smaller gold document among larger distractions can throw your pipeline off course. Basically, practitioners needs to keep an eye not only on the position of the likely gold document but also on its size relative to others. 📄Read the preprint: arxiv.org/abs/2505.18148 Work lead by Owen Bianchi and other collaborators at @DataTecnica
Daniel Khashabi 🕊️ tweet media
English
3
17
52
4K
Mathew Koretsky retuiteado
Brain
Brain@Brain1878·
Koretsky et al. use genome-wide data to cluster patients based on genetic status across risk variants for five neurodegenerative disorders. The results suggest that neurodegenerative diseases have more overlapping genetic aetiology than previously assumed. tinyurl.com/yt39brkt
Brain tweet media
English
0
8
27
9.4K